MedTrace Logo

Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa

NCT05414097 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 348

Last updated 2024-04-15

No results posted yet for this study

Summary

The primary aim of the study explore drivers of cervical cancer screening and barriers contributing to low screening coverage among women in South Africa. Secondary aims are determining preferences for cervical cancer prevention services using a discrete choice experiment and developing a multi-level package of interventions that will address barriers to cervical cancer screening and improve engagement in care among women.

Conditions

Interventions

OTHER

Semi-structured focus group discussions - Women

Semi-structured focus group discussions to explore women's experiences with cervical cancer screening and treatment.

OTHER

semi-structured focus groups discussions - Men

Semi-structured focus group discussions to explore partner dynamics related to women's ability to access cancer screening.

OTHER

In-depth key stakeholders interviews

In-depth interviews to contextualise findings from women and men focus group discussions.

OTHER

Discrete Choice Experiment - Women

Discrete Choice Experiment to determine preferences to different cancer screening models.

OTHER

Development and User Pre-testing Workshops

Development and User Pre-testing Workshops to explore acceptability and feasibility of proposed interventions designed using findings from Phases 1 \&2.

Sponsors & Collaborators

  • Fogarty International Center of the National Institute of Health

    collaborator NIH

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Carla Chibwesha, MD, MSc · Department of Obstetrics and Gynecology University of North Carolina at Chapel Hill

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-16
Primary Completion
2023-10-20
Completion
2023-10-20

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05414097 on ClinicalTrials.gov